CYP2W1 Antibodies

Santa Cruz Biotechnology provides a broad selection of CYP2W1 monoclonal antibodies for research focused on understanding this important protein. The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP2W1 is a member of the cytochrome P450 superfamily, which plays a crucial role in the metabolism of various endogenous and exogenous compounds. CYP2W1 has gained significant attention in cancer research due to its involvement in prodrug metabolism and carcinogen activation. Research into CYP2W1 continues to reveal new insights about drug metabolism pathways and potential therapeutic targets. Scientists worldwide are actively studying CYP2W1 to better understand its role in both normal cellular processes and disease states. Investigating CYP2W1 expression patterns and activity levels can lead to breakthroughs in personalized medicine approaches. Current research suggests that CYP2W1 may serve as a promising target for developing new cancer treatments. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of CYP2W1 and its impact on human health.